<DOC>
	<DOC>NCT02020902</DOC>
	<brief_summary>This is a post-marketing surveillance study on a marketed cetrizine hydrochloride formulation.</brief_summary>
	<brief_title>Post Marketing Surveillance for Contac Bien Z in Japan</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<criteria>Male and female participants, between 1565 years of age, who purchase the marketed cetrizine hydrochloride formulation Who have ever experienced allergic symptoms by taking this medication or any component of this medication, piperazine derivative (including levocetirizine, hydroxizine) Those who have been under 15en diagnosed with kidney disease Children under 15 years of age</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>